Breast cancer is the most commonly diagnosed cancer (other than skin cancer) among women in the United States. Each year, approximately 180,000 people will be diagnosed with invasive breast cancer and more than 60,000 will be diagnosed with in situ breast cancer. In order to reduce these numbers, researchers continue to explore new approaches to breast cancer prevention. Progress is also being made in the early detection and treatment of breast cancer. Mammographic screening continues to be refined, and the use of additional screening tests, such as magnetic resonance imaging (MRI), may provide a benefit to high-risk women. Advances in surgery, radiation, and targeted therapies for breast cancer, as well as novel hormonal and chemotherapy treatment approaches, have also contributed to improved breast cancer survival. Currently, there are an estimated 2.4 million breast cancer survivors in the United States. Other advances include improved supportive care, which makes breast cancer treatment more tolerable, and more personalized breast cancer treatment. The emerging science of genomics, for example, has made it possible to identify individuals who may not need chemotherapy. Understanding breast cancer treatment options, the role of different doctors specializing in the treatment of breast cancer, and how and when to access new and innovative breast cancer treatment options available through clinical trials is essential in order to achieve the best outcome from breast cancer treatment. The Cancer Consultants Breast Cancer Information Center has been designed to help patients understand options for breast cancer prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of breast cancer.